Patent Yard Sign in
Canadian application, no grantCanada

Compositions and methods for the treatment and diagnosis of breast cancer

CA 2242340 A1 · Owner: Reed, Steven G. · Inventors: Reed, Steven G.; Smith, John M.; Frudakis, Tony N.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Compositions and methods for the detection and therapy of breast cancer are disclosed. The compounds provided include nucleotide sequences that are preferentially expressed in breast tumor tissue as well as polypeptides , encoded by such nucleotide sequences. Vaccines and pharmaceutical compositions comprising such compounds are also provided and may be used for example, for , the prevention and treatment of breast cancer. The polypeptides may also be used for the production of antibodies, which are useful for diagnosing and monitoring the progression of breast cancer in a patient.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed January 10, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 10, 2017.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 10, 2019.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJanuary 10, 1997
GrantedNo grant recorded
Term endedJanuary 10, 2017
Patent numberCA 2242340 A1
Classification (IPC)C12N15/12 +2 more

Timeline

Timeline From CIPO dates

1998200020022004200620082010201220142016Application filedJan 10, 1997Term endedJan 10, 2017

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.